Control of malaria by bio-therapeutics and drug delivery systems
Al Qaraghuli, Mohammed M and Obeid, Mohammad A and Aldulaimi, Omar and Ferro, Valerie A (2017) Control of malaria by bio-therapeutics and drug delivery systems. Journal of Medical Microbiology & Diagnosis, 6 (3). 1000260. (https://doi.org/10.4172/2161-0703.1000260)
Preview |
Text.
Filename: Al_Qaraghuli_etal_MMD_2017_Control_of_malaria_by_bio_therapeutics_and_drug_delivery_systems.pdf
Final Published Version License: Download (822kB)| Preview |
Abstract
Malaria is an ubiquitous disease that can affect more than 40% of the world’s population who live with some risk of contracting this disease. The World Health Organization (WHO) has recently highlighted the high spread of this disease in Sub-Saharan Africa. Despite the considerable fall in mortality rate over the past decade, the development of resistance against main treatment strategies still exists. This problem has provoked scientific efforts to develop various treatment strategies including use of vaccines, drug delivery systems, and biotherapeutics approaches. A vaccination strategy is being implemented to trigger direct clearance of the causative parasites from the human host. However, the complex life-cycle of Plasmodium parasites with continuous antigenic mutations has partly hindered this approach so far. The application of different types of drug delivery systems for the delivery of anti-malarial drugs is also being considered in order to improve the efficacy, pharmacokinetics, tolerability, and reduce toxicity of existing anti-malarial drugs. A third approach has emerged from the high success of antibodies to treat complex diseases like cancer and autoimmune diseases. Various antibody engineering methods and formats have been proposed to tackle the notable sophisticated lifecycle of malaria. Within the malaria research field, the characteristics of these diverse treatment strategies, individually, are broadly acknowledged. This review article considers the current status of these approaches and the future outlook.
ORCID iDs
Al Qaraghuli, Mohammed M ORCID: https://orcid.org/0000-0003-1823-6671, Obeid, Mohammad A ORCID: https://orcid.org/0000-0003-0244-8370, Aldulaimi, Omar and Ferro, Valerie A ORCID: https://orcid.org/0000-0003-1967-3603;-
-
Item type: Article ID code: 61900 Dates: DateEvent18 September 2017Published5 September 2017AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Engineering > Chemical and Process Engineering
Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical SciencesDepositing user: Pure Administrator Date deposited: 02 Oct 2017 11:16 Last modified: 11 Nov 2024 11:47 URI: https://strathprints.strath.ac.uk/id/eprint/61900